Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. Jun28
    Diverse Populations Participating in Decisions About Your Care With Your Health Care Team
    Tags:
    black or african americandoctor-patient communicationhealth care disparitieshealth care professionalslgbtq+treatment
    Register

Past workshops

For All Cancers

    1. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips and Strategies to Find the Best Cancer Treatment and Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
      Tags:
      biomarkersblack or african americandoctor-patient communicationgenomicshealth care disparitiesside effectstreatmenthealth care professionalslgbtq+
    2. Diverse Populations Participating in Decisions about Your Care with Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
      Tags:
      black or african americanhealth care disparitieshealth care professionalslgbtq+treatmentdoctor-patient communication
    3. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips & Strategies to Find the Best Cancer Treatment & Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
      Tags:
      doctor-patient communicationhealth care disparitiesside effectstreatmentcoronavirusgenomicsbiomarkers
    4. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
      Tags:
      doctor-patient communication
    5. COVID-19, Omicron & Delta Variants, COVID-19 Vaccines & Booster Vaccines: Revised Guidelines for People Living with Cancer and Their Loved Ones
      Tags:
      coronavirusdoctor-patient communication
    6. How Health Care Disparities May Influence Your Cancer Treatment & Care
      Tags:
      doctor-patient communicationhealth care disparitiestreatmentblack or african american
    7. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
      Tags:
      doctor-patient communicationtreatment
    8. Cancer and Flu Shots
      Tags:
      adherencedoctor-patient communicationpost-treatment survivorshiptreatment
    9. Participating in Decisions about Your CarePart IV of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      caregivingcopingdoctor-patient communicationside effectscare planningtreatment
    10. Participating in Decisions about Your CarePart V of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      doctor-patient communicationtreatmentcare planning
    11. For Caregivers: Care Coordination for Your Loved One Living with Cancer and Other Health ProblemsPart IV of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      care planningcaregivingdoctor-patient communication
    12. Understanding the Costs of Care and Your Health Care CoveragePart III of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      financial assistanceinsurancemedicarecare planningdoctor-patient communicationcoping
    13. Managing the Costs of Living with Cancer
      Tags:
      financial assistanceinsurancecopingdoctor-patient communication
    14. For Health Care Professionals: Care Coordination for Older Men Living with Cancer
      Tags:
      older adultsdoctor-patient communicationhealth care professionals
    15. Communicating with Your Health Care Team After Treatment: Making the Most of Your VisitPart II of The Eighth Annual Cancer Survivorship Series: Living With, Through and Beyond Cancer
      Tags:
      post-treatment survivorshipdoctor-patient communicationadvocacy
    16. The Importance of Communicating with Your Doctor About Follow-Up CarePart I of The Sixth Annual Cancer Survivorship Series: Living With, Through and Beyond Cancer
      Tags:
      post-treatment survivorshipdoctor-patient communication

For Acute Lymphoblastic Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Acute Myeloid Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Bladder Cancer

    1. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer
      Tags:
      bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments
    2. For Caregivers: Informative Tips to Cope with Your Loved One’s Bladder CancerPart II of Life with Bladder Cancer
      Tags:
      bladder cancercaregivingdoctor-patient communication
    3. Bladder Cancer: Treatment UpdatesPart I of Life with Bladder Cancer
      Tags:
      bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments

For Breast Cancer

    1. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques
    2. Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart III of Living with Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancercaregivingdoctor-patient communicationholidaysstress
    3. Triple Negative Breast Cancer and Fear of RecurrencePart II of Living with Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancerrecurrencedoctor-patient communicationmind-bodystresscare planning

For Chronic Lymphocytic Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Chronic Myelogenous Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Cutaneous T-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Diffuse Large B-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Follicular Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Hodgkin Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Lung Cancer

    1. Non-Small Cell Lung Cancer: For Caregivers – Practical Tips for CopingPart III of Living with Non-Small Cell Lung Cancer
      Tags:
      lung cancercaregivingcopingdoctor-patient communication
    2. Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
      Tags:
      lung cancertreatmentcoronavirusdoctor-patient communicationside effects

For Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Mantle Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Marginal Zone Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options
      Tags:
      mesotheliomatreatmentchemotherapyimmunotherapypersonalized medicinetargeted treatmentsside effectsclinical trialsdoctor-patient communication

For Metastatic Breast Cancer

    1. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques

For Multiple Myeloma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Coping with the Stresses of Caregiving When Your Loved One Has Multiple MyelomaPart II of Living with Multiple Myeloma
      Tags:
      multiple myelomacaregivingdoctor-patient communicationtreatment
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
    4. Progress in the Treatment of Multiple Myeloma
      Tags:
      multiple myelomatreatmentbone marrow transplantbone healthclinical trialsdoctor-patient communicationneuropathypainside effects

For Myelodysplastic Syndromes

    1. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Myeloproliferative Neoplasms

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Non-Hodgkin Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Peripheral T-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Small Lymphocytic Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Triple Negative Breast Cancer

    1. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques
    2. Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart III of Living with Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancercaregivingdoctor-patient communicationholidaysstress
    3. Triple Negative Breast Cancer and Fear of RecurrencePart II of Living with Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancerrecurrencedoctor-patient communicationmind-bodystresscare planning
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.